Zealand Pharma
622.5 DKK +0.48%9 investors are following this company
Zealand Pharma is a biotechnology company. Particular focus is found in the development of drugs for the treatment of diabetes and various intestinal diseases. The company has a varied product portfolio with separate brands that are sold on a global level. The largest business is in the Nordic market. Zealand Pharma was founded in 1997 and is headquartered in Söborg, Denmark.
Revenue
342.79M
EBIT %
-166.94 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
ZEAL
Daily low / high price
600.5 / 624.5
DKK
Market cap
39B DKK
Turnover
123.69M DKK
Volume
201K
Latest videos
Financial calendar
Interim report
16.05.2024
Interim report
15.08.2024
Interim report
07.11.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Van Herk Investments | 16.8 % | 16.8 % |
Credit Suisse Group AG | 6.2 % | 6.2 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools